Apex Neuro Inventions May Be Poised to Impact the Neuromodulation Field
Investment in patents always leads market activity. So Apex Neuro’s investments in key research and development implicate its positioning for market launch in the coming years.
So far, Patent Forecast shows 5 patent assets from Apex Neuro since 2019. All 5 relate to AI-driven electrophysiological neuromodulation of the brain. Most people have never heard of Apex Neuro because the company is not yet selling products, advertising, or even operating a fully functional website. That being said, that patent data does not lie. Apex Neuro is actively seeking patent protection in the Neuromodulation field, and competitors such as Boston Scientific, Philips, Psomagen Inc., Halo Neuro, and Neurosteer should take note.
To stay on top of the most recent patent data and be the first to know when a competitor enters your field, make sure to check out the various interactive AI Biotech/Diagnostics sectors available through the Patent Forecast®.
Related Posts
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…